Articles & Issues

Alert me when new Articles in Press are available. Add Articles in Press Alert   Request Articles in Press Alert via email or RSS Feed   Request RSS feed of Articles in Press

78 Articles

Article Title Author(s) Type (Status) Available Online
Retraction notice to “Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines” [Leuk. Res. 30 (2006) 313–321]

DOI: 10.1016/j.leukres.2012.01.014

Mariko Tomita, Hirochika Kawakami, Jun-nosuke Uchihara, Taeko Okudaira, Masato Masuda, Nobuyuki Takasu, Takehiro Matsuda, Takao Ohta, Yuetsu Tanaka, Naoki Mori et al. Erratum
(In Press Corrected Proof)
free full text
22 February 2012
Vitamin D protects acute lymphoblastic leukemia cells from dexamethasone

DOI: 10.1016/j.leukres.2012.01.011

Reuben Antony, Xia Sheng, Ehsan A. Ehsanipour, Emily Ng, Rocky Pramanik, Lars Klemm, Brian Ichihara, Steven D. Mittelman et al. Short communication
(In Press Corrected Proof)
20 February 2012
Post-transcriptional modulation of C/EBPα prompts monocytic differentiation and apoptosis in acute myelomonocytic leukaemia cells

DOI: 10.1016/j.leukres.2012.01.009

Hideki Yoshida, Toshihiko Imamura, Atsushi Fujiki, Yoshifumi Hirashima, Mitsuru Miyachi, Takeshi Inukai, Hajime Hosoi et al. Full-length article
(In Press Corrected Proof)
20 February 2012
Thrombomodulin-induced differentiation of acute myelomonocytic leukemia cells via JNK signaling

DOI: 10.1016/j.leukres.2012.01.019

Jing Yang, Takayuki Ikezoe, Chie Nishioka, Goichi Honda, Akihito Yokoyama et al. Full-length article
(In Press Corrected Proof)
20 February 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro

DOI: 10.1016/j.leukres.2012.01.020

Gerard J. Madlambayan, Eric Bartee, Manbok Kim, Masmudur M. Rahman, Amy Meacham, Edward W. Scott, Grant McFadden, Christopher R. Cogle et al. Full-length article
(In Press Corrected Proof)
20 February 2012
Development of a multiplex PCR assay for the detection of genomic copy number changes in myelodysplastic syndromes

DOI: 10.1016/j.leukres.2012.01.007

Aspasia Stamatoullas, Agathe Waultier, Fabrice Jardin, Marie Paule Callat, Françoise Parmentier, Celine Burgot, Dominique Penther, Hervé Tilly, Christian Bastard et al. Correspondence
(In Press Corrected Proof)
17 February 2012
Establishment and characterization of a new human acute myelomonocytic leukemia cell line JIH-3

DOI: 10.1016/j.leukres.2012.01.012

Jinlan Pan, Yongquan Xue, Suning Chen, Huiying Qiu, Chunxiao Wu, Hui Jiang, Qian Wang, Jun Zhang, Suxiao Bai, Yafang Wu, Yong Wang, Juan Shen et al. Full-length article
(In Press Corrected Proof)
16 February 2012
Book review

DOI: 10.1016/j.leukres.2012.01.016

Paul G. Rothberg Book review
(In Press Corrected Proof)
15 February 2012
RBC-transfusion guidelines update

DOI: 10.1016/j.leukres.2012.01.023

R.P. Gale, G. Barosi, T. Barbui, F. Cervantes, K. Dohner, B. Dupriez, V. Gupta, C. Harrison, R. Hoffman, J.J. Kiladjian, R. Mesa, M.F. Mc Mullin, F. Passamonti, V. Ribrag, G. Roboz, G. Saglio, A. Vannucchi, S. Verstovsek et al. Correspondence
(In Press Corrected Proof)
15 February 2012
Transfusions at home in patients with myelodysplastic syndromes

DOI: 10.1016/j.leukres.2012.01.010

Pasquale Niscola, Andrea Tendas, Marco Giovannini, Luca Cupelli, Malgorzata Monika Trawinska, Massimiliano Palombi, Laura Scaramucci, Gregorio Antonio Brunetti, Alessio Perrotti, Benedetta Neri, Fabio Efficace, Claudio Cartoni, Paolo de Fabritiis, Franco Mandelli et al. Full-length article
(In Press Corrected Proof)
15 February 2012
High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients

DOI: 10.1016/j.leukres.2012.01.017

Aleksandra Butrym, Miroslaw Majewski, Justyna Dzietczenia, Kazimierz Kuliczkowski, Grzegorz Mazur et al. Full-length article
(In Press Corrected Proof)
14 February 2012
The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential Thrombocythemia

DOI: 10.1016/j.leukres.2012.01.008

Mathilde Födermayr, Otto Zach, Maria Huber, Sigrid Machherndl-Spandl, Soraya Wölfl, Hans-Christian Bösmüller, Sonja Hasenschwandtner, Sonja Burgstaller, Otto Krieger, Dieter Lutz, Ansgar Weltermann, Hanns Hauser et al. Short communication
(In Press Corrected Proof)
13 February 2012
The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac

DOI: 10.1016/j.leukres.2011.12.024

Sampath Ramachandiran, Joan Cain, Albert Liao, Yanjuan He, Xiangxue Guo, Lawrence H. Boise, Haian Fu, Lee Ratner, Hanna Jean Khoury, Leon Bernal-Mizrachi et al. Full-length article
(In Press Corrected Proof)
13 February 2012
Neutropenia at baseline could indicate poor prognosis in low/intermediate risk myelodysplastic syndrome patients

DOI: 10.1016/j.leukres.2012.01.003

Massimo Breccia, Giuseppina Loglisci, Adriano Salaroli, Paola Finsinger, Alessandra Serrao, Luigi Petrucci, Giuliana Alimena et al. Discussion
(In Press Corrected Proof)
10 February 2012
A novel three-way variant t(4;17;5)(p16;q23;q31) in a case of secondary plasma cell leukemia

DOI: 10.1016/j.leukres.2012.01.004

Yoonjung Kim, Juwon Kim, Seo-Jin Park, Jong Rak Choi, Kyung-A Lee, Yu Ri Kim et al. Correspondence
(In Press Corrected Proof)
10 February 2012
AZA-ESA combo: A new standard for higher risk MDS?

DOI: 10.1016/j.leukres.2012.01.002

Moshe Mittelman Editorial
(In Press Corrected Proof)
10 February 2012
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?

DOI: 10.1016/j.leukres.2011.12.019

Gail J. Roboz, Usama Wissa, Ellen K. Ritchie, Usama Gergis, Sebastian Mayer, Joseph M. Scandura, Paul J. Christos, Eric J. Feldman et al. Full-length article
(In Press Corrected Proof)
10 February 2012
Sequential array comparative genomic hybridization analysis identifies copy number changes during blastic transformation of chronic myeloid leukemia

DOI: 10.1016/j.leukres.2011.12.021

Seung-Tae Lee, Yongick Ji, Hee-Jin Kim, Chang-Seok Ki, Chul Won Jung, Jong-Won Kim, Sun-Hee Kim et al. Full-length article
(In Press Corrected Proof)
10 February 2012
A tribute to Professor Terence “Terry” John Hamblin

DOI: 10.1016/j.leukres.2012.01.013

John M. Bennett, Daniel Catovsky, David Bowen Personal report
(In Press Corrected Proof)
06 February 2012
Abl-interactor 2 (ABI2): A novel MLL translocation partner in acute myeloid leukemia

DOI: 10.1016/j.leukres.2012.01.005

Eva A. Coenen, C. Michel Zwaan, Claus Meyer, Rolf Marschalek, Ursula Creutzig, Rob Pieters, Jutta Bradtke, Marry M. van den Heuvel-Eibrink et al. Correspondence
(In Press Corrected Proof)
03 February 2012
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes

DOI: 10.1016/j.leukres.2012.01.006

Uwe Platzbecker, Lorenz C. Hofbauer, Gerhard Ehninger, Kristina Hölig Review article
(In Press Corrected Proof)
02 February 2012
Differential diagnosis of paediatric bone pain: Acute lymphoblastic leukemia

DOI: 10.1016/j.leukres.2012.01.001

Nicolien van der Have, Shriram Vaidia Nath, Colin Story, Heather Tapp, C. Nicola, Sarah Moore, Rosemary Sutton, Tamas Revesz et al. Short communication
(In Press Corrected Proof)
30 January 2012
Cytarabine in relapsed acute myeloid leukemia

DOI: 10.1016/j.leukres.2011.12.001

Brandon M. Hardesty, Larry D. Cripe Editorial
(In Press Corrected Proof)
30 January 2012
The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line

DOI: 10.1016/j.leukres.2011.12.018

Hongyun Xing, Xi Yang, Ting Liu, Juan Lin, Xiaoyi Chen, Yuping Gong et al. Full-length article
(In Press Corrected Proof)
30 January 2012
Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies

DOI: 10.1016/j.leukres.2011.12.020

Jorge J. Castillo, John L. Reagan, Randall R. Ingham, Michael Furman, Samir Dalia, Basma Merhi, Saed Nemr, Ali Zarrabi, Joanna Mitri et al. Full-length article
(In Press Corrected Proof)
30 January 2012
Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC)

DOI: 10.1016/j.leukres.2011.12.014

Marie Jarosova, Radka Nedomova, Jaromir Hubacek, Milena Holzerova, Pavla Mickova, Beata Katrincsakova, Zuzana Pikalova, Tomas Papajik, Karel Indrak et al. Correspondence
(In Press Corrected Proof)
27 January 2012
The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP

DOI: 10.1016/j.leukres.2011.12.012

Jorge J. Castillo, Brady E. Beltran, Moo-Kon Song, Ivana Ilic, Sirpa Leppa, Heidi Nurmi, Ritsuko Seki, Silvia Uccella, Jun-Min Li, Diana O. Treaba, Dariusz Stachurski, James N. Butera et al. Full-length article
(In Press Corrected Proof)
27 January 2012
A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes

DOI: 10.1016/j.leukres.2011.12.023

Wei Wei, Fan Zhou, Yizi Zhang, Lieping Guo, Haotian Shi, Jian Hou et al. Full-length article
(In Press Corrected Proof)
27 January 2012
Isolation of siRNA target by biotinylated siRNA reveals that human CCDC12 promotes early erythroid differentiation

DOI: 10.1016/j.leukres.2011.12.017

Cuiqing Fan, Lin Dong, Ning Zhu, Yuan Xiong, Jiewen Zhang, Le Wang, Yan Shen, Xiaoyin Zhang, Meihong Chen et al. Full-length article
(In Press Corrected Proof)
24 January 2012
The minimal residual disease concept coming of age – Now for the direct comparison of methodologies

DOI: 10.1016/j.leukres.2011.12.022

Hans Beier Ommen, Anne Stidsholt Roug, Peter Hokland Editorial
(In Press Corrected Proof)
20 January 2012
A comprehensive cytogenetic classification of 1466 Chinese patients with de novo acute lymphoblastic leukemia

DOI: 10.1016/j.leukres.2011.12.016

Xin Li, Juan Li, Yanjie Hu, Wei Xie, Wen Du, Wei Liu, Xiaoqing Li, Xiangjun Chen, Hongrui Li, Junfeng Wang, Lannan Zhang, Shiang Huang et al. Full-length article
(In Press Corrected Proof)
20 January 2012
A rare cryptic and complex rearrangement leading to MLL-MLLT10 gene fusion masked by del(10)(p12) in a child with acute monoblastic leukemia (AML-M5)

DOI: 10.1016/j.leukres.2011.12.009

Amanda Faria de Figueiredo, Tarsis Paiva Vieira, Thomas Liehr, Samarth Bhatt, Mariana Tavares de Souza, Renata Binato, Terezinha de Jesus Marques-Salles, Edna Carboni, Raul C. Ribeiro, Maria Luiza Macedo Silva, Eliana Abdelhay et al. Correspondence
(In Press Corrected Proof)
19 January 2012
PDS5A, a novel translocation partner of MLL in acute myeloid leukemia

DOI: 10.1016/j.leukres.2011.12.006

Natalie Put, Katrien Van Roosbroeck, Isabelle Vande Broek, Lucienne Michaux, Peter Vandenberghe et al. Correspondence
(In Press Corrected Proof)
10 January 2012
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine

DOI: 10.1016/j.leukres.2011.11.024

Francesca Buchi, Elena Spinelli, Erico Masala, Antonella Gozzini, Alessandro Sanna, Alberto Bosi, Germano Ferrari, Valeria Santini et al. Full-length article
(In Press Corrected Proof)
10 January 2012
Hypomethylating therapy and autoimmunity in MDS: An enigmatic relationship

DOI: 10.1016/j.leukres.2011.12.013

Ioannis Kotsianidis, Emmanouil Spanoudakis, Evangelia Nakou, Paraskevi Miltiades, Dimitrios Margaritis, Costas Tsatalas, Argyrios Tzouvelekis, Anastasia Oikonomou et al. Correspondence
(In Press Corrected Proof)
09 January 2012
Fludarabine and a histone deacetylase inhibitor – Strange bedfellows

DOI: 10.1016/j.leukres.2011.12.005

H. Miles Prince Editorial
(In Press Corrected Proof)
09 January 2012
Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia

DOI: 10.1016/j.leukres.2011.12.010

Francis Giles, David Rizzieri, Farhad Ravandi, Ronan Swords, Tove Flem Jacobsen, Susan O’Brien et al. Correspondence
(In Press Corrected Proof)
09 January 2012
A novel recurrent translocation t(7;17)(q22;p13) and a late-appearing t(2;3)(p13;q26.2) with dysmegakaryopoiesis in acute myeloid leukemia

DOI: 10.1016/j.leukres.2011.12.007

Katsuya Yamamoto, Atsuo Okamura, Yumiko Inui, Kimikazu Yakushijin, Hiroshi Matsuoka, Hironobu Minami et al. Correspondence
(In Press Corrected Proof)
09 January 2012
Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia

DOI: 10.1016/j.leukres.2011.12.015

Stephen E. Langabeer, Fiona Quinn, David O’Brien, Anthony M. McElligott, Johanna Kelly, Paul V. Browne, Elisabeth Vandenberghe et al. Short communication
(In Press Corrected Proof)
09 January 2012
N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia

DOI: 10.1016/j.leukres.2011.12.008

Tereza Lopotová, Sylvie Nádvorníková, Markéta Žáčková, Jaroslav Polák, Jiří Schwarz, Hana Klamová, Jana Moravcová et al. Correspondence
(In Press Corrected Proof)
09 January 2012
RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina

DOI: 10.1016/j.leukres.2011.12.003

Cristina N. Alonso, Marta S. Gallego, Jorge G. Rossi, Adriana Medina, Patricia L. Rubio, Andrea R. Bernasconi, Pedro A. Zubizarreta, María S. Felice et al. Full-length article
(In Press Corrected Proof)
09 January 2012
Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro

DOI: 10.1016/j.leukres.2011.11.014

You Qin, Chun-Yan Sun, Fu-Rong Lu, Xiang-Rong Shu, Di Yang, Lei Chen, Xiao-Mei She, Nicholas Miller Gregg, Tao Guo, Yu Hu et al. Full-length article
(In Press Corrected Proof)
06 January 2012
Nilotinib-mediated increase in fasting glucose level is reversible, does not convert to type 2 diabetes and is likely correlated with increased body mass index

DOI: 10.1016/j.leukres.2011.12.011

Massimo Breccia, Giuseppina Loglisci, Adriano Salaroli, Alessandra Serrao, Giuliana Alimena et al. Correspondence
(In Press Corrected Proof)
04 January 2012
Potentiation of Nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML

DOI: 10.1016/j.leukres.2011.12.002

Rajesh R. Nair, Joel H. Tolentino, Raul F. Argilagos, Ling Zhang, Javier Pinilla-Ibarz, Lori A. Hazlehurst et al. Full-length article
(In Press Corrected Proof)
04 January 2012
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)

DOI: 10.1016/j.leukres.2011.12.004

M. Mansour Ceesay, Estella Matutes, Graham P. Taylor, Paul Fields, Jamie Cavenagh, Sylwia Simpson, Aloysius Ho, Stephen Devereux, Ghulam J. Mufti, Antonio Pagliuca et al. Full-length article
(In Press Corrected Proof)
03 January 2012
Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: Outcomes of prolonged therapy

DOI: 10.1016/j.leukres.2011.11.022

Vasiliki Pappa, Konstantinos Girkas, Constantina Sambani, Sotiris Pagageorgiou, Panagiotis Tsirigiotis, Kiki Karvounis, Evangelia Stathopoulou, Theofanis Economopoulos, George Dimitriadis, Ioannis Dervenoulas et al. Correspondence
(In Press Corrected Proof)
28 December 2011
Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia

DOI: 10.1016/j.leukres.2011.11.017

Sebastian Francis, David Bareford, Christina Baginott, Jecko Thachil Short communication
(In Press Corrected Proof)
26 December 2011
The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children

DOI: 10.1016/j.leukres.2011.11.015

Yoichi Tanaka, Atsushi Manabe, Hisaya Nakadate, Kensuke Kondoh, Kozue Nakamura, Katsuyoshi Koh, Tomoyuki Utano, Akira Kikuchi, Takako Komiyama et al. Full-length article
(In Press Corrected Proof)
26 December 2011
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets

DOI: 10.1016/j.leukres.2011.11.020

Giovanni Rossi, Maria Marta Minervini, Angelo Michele Carella, Chiara de Waure, Francesco di Nardo, Lorella Melillo, Giovanni D’Arena, Gina Zini, Nicola Cascavilla et al. Full-length article
(In Press Corrected Proof)
26 December 2011
The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients

DOI: 10.1016/j.leukres.2011.11.021

Aleksandar Savic, Vanja Kvrgic, Nebojsa Rajic, Ivana Urosevic, Dragan Kovacevic, Ivanka Percic, Stevan Popovic et al. Short communication
(In Press Corrected Proof)
22 December 2011
Long-term transfusion independence in del(5q) MDS patients after short term therapy with lenalidomide: 2 new cases

DOI: 10.1016/j.leukres.2011.11.023

Andreas Himmelmann, Joëlle Tchinda Correspondence
(In Press Corrected Proof)
19 December 2011
Immune-mediated peripheral neuropathy occurring simultaneously with recurrent graft-versus-host disease after allogenic hematopoietic stem cell transplantation

DOI: 10.1016/j.leukres.2011.11.025

Yukiko Doi, Hiroyuki Sugahara, Kazutaka Yamamoto, Hidetoshi Uji-ie, Tsunayuki Kakimoto, Hiroto Sakoda et al. Correspondence
(In Press Corrected Proof)
19 December 2011
Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasms

DOI: 10.1016/j.leukres.2011.11.018

Christen Lykkegaard Andersen, Hans Hasselbalch, Kirsten Grønbæk Short communication
(In Press Corrected Proof)
19 December 2011
Tumor necrosis factor alpha−308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt

DOI: 10.1016/j.leukres.2011.11.016

Azza Ibrahim, Hala Abdel Rahman, Mervat Khorshied, Rania Sami, Nelly Nasr, Ola Khorshid et al. Full-length article
(In Press Corrected Proof)
19 December 2011
Glycogen synthase kinase-3 (GSK-3) inhibition induces apoptosis in leukemic cells through mitochondria-dependent pathway

DOI: 10.1016/j.leukres.2011.11.013

Mohammad Reza Mirlashari, Ingrid Randen, Jens Kjeldsen-Kragh Full-length article
(In Press Corrected Proof)
19 December 2011
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?

DOI: 10.1016/j.leukres.2011.11.019

R. Itzykson, S. Thépot, O. Beyne-Rauzy, S. Ame, F. Isnard, F. Dreyfus, C. Salanoubat, A.L. Taksin, Y. Chelgoum, C. Berthon, J.V. Malfuson, L. Legros, N. Vey, P. Turlure, C. Gardin, S. Boehrer, L. Ades, P. Fenaux, on behalf of the Groupe Francophone des Myelodysplasies (GFM) et al. Full-length article
(In Press Corrected Proof)
19 December 2011
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia

DOI: 10.1016/j.leukres.2011.10.027

Steven M. Trifilio, Alfred W. Rademaker, Diane Newman, Katherine Coyle, Katrin Carlson-Leuer, Jayesh Mehta, Jessica Altman, Olga Frankfurt, Martin S. Tallman et al. Full-length article
(In Press Corrected Proof)
16 December 2011
Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study

DOI: 10.1016/j.leukres.2011.11.011

Akira Matsuda, Masafumi Taniwaki, Itsuro Jinnai, Hironori Harada, Mitsumasa Watanabe, Kenshi Suzuki, Soshi Yanagita, Takahiro Suzuki, Yataro Yoshida, Akiro Kimura, Mitsuru Tsudo, Kaoru Tohyama, Masaaki Takatoku, Keiya Ozawa et al. Full-length article
(In Press Corrected Proof)
16 December 2011
The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation

DOI: 10.1016/j.leukres.2011.11.009

Masatsugu Tanaka, Shoichi Kobayashi, Ayumi Numata, Takayoshi Tachibana, Hirotaka Takasaki, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori et al. Full-length article
(In Press Corrected Proof)
15 December 2011
Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia

DOI: 10.1016/j.leukres.2011.10.023

Virginia M. Klimek, Emily K. Dolezal, Larry Smith, Gerald Soff, Stephen D. Nimer et al. Full-length article
(In Press Corrected Proof)
12 December 2011


Note to users: The section "Articles in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. There are three types of "Articles in Press":
  • Accepted Manuscripts: these are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication.
  • Uncorrected proofs: these are articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Uncorrected proofs may be temporarily unavailable for production reasons.
  • Corrected proofs: these are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.